IL291224A - New molecules for diagnosis - Google Patents
New molecules for diagnosisInfo
- Publication number
- IL291224A IL291224A IL291224A IL29122422A IL291224A IL 291224 A IL291224 A IL 291224A IL 291224 A IL291224 A IL 291224A IL 29122422 A IL29122422 A IL 29122422A IL 291224 A IL291224 A IL 291224A
- Authority
- IL
- Israel
- Prior art keywords
- diagnosis
- novel molecules
- molecules
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19196512 | 2019-09-10 | ||
| EP20184340 | 2020-07-06 | ||
| PCT/EP2020/075420 WO2021048324A1 (en) | 2019-09-10 | 2020-09-10 | Novel molecules for diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL291224A true IL291224A (en) | 2022-05-01 |
Family
ID=72356005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL291224A IL291224A (en) | 2019-09-10 | 2022-03-09 | New molecules for diagnosis |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230034474A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4028127A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022547993A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220087439A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114650866B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020347483A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3149837A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL291224A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022002873A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021048324A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4649091A2 (en) * | 2023-01-12 | 2025-11-19 | University Of Virginia Patent Foundation | Anti-cith3 antibodies and uses thereof |
| WO2025134068A1 (en) | 2023-12-22 | 2025-06-26 | Ac Immune Sa | Antibody drug conjugates targeting proteinopathies, and uses thereof |
| CN117567635B (zh) * | 2024-01-16 | 2024-05-14 | 恺佧生物科技(上海)有限公司 | 抗Cas9酶的抗体及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030068316A1 (en) * | 1997-02-05 | 2003-04-10 | Klein William L. | Anti-ADDL antibodies and uses thereof |
| US6750324B1 (en) * | 1997-12-02 | 2004-06-15 | Neuralab Limited | Humanized and chimeric N-terminal amyloid beta-antibodies |
| KR20070094890A (ko) * | 2004-10-25 | 2007-09-27 | 머크 앤드 캄파니 인코포레이티드 | 안티 addl 항체 및 그 용도 |
| CA2690434C (en) * | 2007-06-12 | 2018-05-22 | Ac Immune S.A. | Monoclonal anti beta amyloid antibody |
| JP2011500059A (ja) * | 2007-10-15 | 2011-01-06 | セントコア・オーソ・バイオテツク・インコーポレーテツド | ヒト抗アミロイド抗体、組成物、方法及び使用 |
| KR20100115340A (ko) * | 2007-10-19 | 2010-10-27 | 이무나스 파마 가부시키가이샤 | Aβ 올리고머에 특이적으로 결합하는 항체 및 그의 이용 |
| CN102596997B (zh) * | 2009-08-06 | 2015-06-03 | 伊缪纳斯制药株式会社 | 特异性结合Aβ寡聚体的抗体及其用途 |
| EP2632434B1 (en) * | 2010-10-26 | 2025-08-20 | AC Immune S.A. | Liposome-based construct comprising a peptide modified through hydrophobic moieties |
-
2020
- 2020-09-10 AU AU2020347483A patent/AU2020347483A1/en active Pending
- 2020-09-10 KR KR1020227011571A patent/KR20220087439A/ko not_active Ceased
- 2020-09-10 CA CA3149837A patent/CA3149837A1/en active Pending
- 2020-09-10 CN CN202080077792.6A patent/CN114650866B/zh active Active
- 2020-09-10 EP EP20767586.9A patent/EP4028127A1/en active Pending
- 2020-09-10 MX MX2022002873A patent/MX2022002873A/es unknown
- 2020-09-10 JP JP2022515903A patent/JP2022547993A/ja active Pending
- 2020-09-10 WO PCT/EP2020/075420 patent/WO2021048324A1/en not_active Ceased
- 2020-09-10 US US17/640,656 patent/US20230034474A1/en active Pending
-
2022
- 2022-03-09 IL IL291224A patent/IL291224A/en unknown
-
2025
- 2025-08-14 JP JP2025135157A patent/JP2025178565A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021048324A9 (en) | 2022-05-05 |
| KR20220087439A (ko) | 2022-06-24 |
| CA3149837A1 (en) | 2021-03-18 |
| EP4028127A1 (en) | 2022-07-20 |
| US20230034474A1 (en) | 2023-02-02 |
| JP2022547993A (ja) | 2022-11-16 |
| WO2021048324A1 (en) | 2021-03-18 |
| AU2020347483A1 (en) | 2022-03-31 |
| CN114650866A (zh) | 2022-06-21 |
| CN114650866B (zh) | 2025-08-01 |
| MX2022002873A (es) | 2022-03-25 |
| JP2025178565A (ja) | 2025-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279219A (en) | New compounds for diagnosis | |
| IL290104A (en) | diagnostic system | |
| GB202018087D0 (en) | No details | |
| SG11202009515RA (en) | Vista antigen-binding molecules | |
| GB202015405D0 (en) | No details | |
| GB202013426D0 (en) | No Details | |
| CA208605S (en) | Instrument | |
| GB202009212D0 (en) | No details | |
| GB201814562D0 (en) | Vista antigen-binding molecules | |
| IL285162A (en) | survival-directed chimeric molecules (surtac) | |
| GB201917229D0 (en) | No details | |
| IL292119A (en) | conjugated molecules | |
| IL289266B1 (en) | New molecules | |
| GB202006205D0 (en) | No details | |
| GB201906221D0 (en) | No details | |
| GB202103639D0 (en) | No details | |
| CA191673S (en) | Diagnostic cartridge | |
| GB201916046D0 (en) | Diagnostic method | |
| GB202008967D0 (en) | No details | |
| IL293228B2 (en) | Diagnostic techniques based on alignment of speech samples | |
| SI3834594T1 (sl) | Kolo s strgalom za sejalnik | |
| GB201908591D0 (en) | Methods for cancer diagnosis | |
| GB202014354D0 (en) | No details | |
| IL282230A (en) | chimeric molecules | |
| GB201904861D0 (en) | Diagnosis |